Therapeutic Effect of Dithiophenolato Chitosan Nanocomposites Against Carbon Tetrachloride-induced Hepatotoxicity in Rats

Abstract

<title>Abstract</title> Our previous study showed that dithiophenolate (DTP) and its chitosan nanoparticles (DTP-CSNPs) have abilities to bind with DNA helixes. So in this study, their lethal doses (LD₅₀) and therapeutic roles against rat liver injuries induced by carbon tetrachloride (CCl₄) were evaluated. The study focused on the determination of the markers of oxidative stress (OS) and apoptosis and compare the results with those of cisplatin treatment. The results revealed that LD50 values of DTP and DTP-CSNPs are 2187.5 and 1462.5 mg/kg, respectively. Treatment with DPT and DPT-CSNPs after CCl4 administration reduced liver injuries, induced by CCl4, and improved liver functions and architecture through the reduction of OS and apoptosis. Where the oxidant marker was decreased with elevations of antioxidant markers. Also, there was an elevation in Bcl 2 value, with decreases in caspase-8, Bax, and Bax/Bcl 2 ratio. DPT-CSNPs treatment gave preferable results than that treated with DPT. Moreover, DTP and DPT-CSNPs treatment gave better results than Cisplatine treatment. The administration of healthy rats with low doses of DTP and DTP-CSNPs for 14 days had no effect. Otherwise, the study on HepG2 cell line showed that DTP and DPT-CSNPs inhibited cell growth by arresting cells in the G2/M phase and inducing cell death. <bold>In conclusion:</bold> DTP and DTP-CSNPs have anti-apoptotic and anti-oxidative stress towards hepatotoxicity induced by CCl4. Moreover, DTP and DTP-CSNPs have anticancer activity against the HepG2 cell line. Generally, DTP-CSNPs are more effective than DTP. So, they can be used in the pharmacological fields, especially DTP-CSNPS.